)
Edge17 Oct 2025
A Castle in the Sky: The Story of Oracle
Oracle's journey from database innovator to disciplined enterprise backbone, now shaping the AI buildout with a standardized cloud infrastructure.
Recce Pharmaceuticals (RCE) investor relations material
Recce Pharmaceuticals H2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H2 2025 earnings summary28 Aug, 2025
Executive summary
Advanced lead anti-infective R327G into Phase 3 registrational trial for diabetic foot infections (DFI) in Indonesia, with interim analysis planned for accelerated approval in H1 2026.
Completed Phase II trial for ABSSSI, achieving 93% efficacy at day 14 and no serious adverse events, supporting further DFI patient enrolment.
Secured A$15.8 million in equity and A$11.5 million in non-dilutive debt, with an additional A$19 million available, ensuring a strong cash runway.
Awarded US$2 million grant from US Department of Defense for burn wound program and entered a research agreement with USAMRIID for biothreat pathogens.
Expanded global patent portfolio, with new patents granted in Australia, Japan, and China, extending protection beyond 2040.
Financial highlights
Total income of $7.7 million, primarily from R&D tax incentives and grants.
Operating loss increased to $21.4 million (2024: $17.7 million), mainly due to higher R&D expenditure.
Cash and cash equivalents at year-end: $10.4 million (2024: $4.4 million).
Net deficiency in equity of $3.1 million, improved from $9.5 million deficit in 2024.
No dividends declared or paid during the year.
Outlook and guidance
Indonesian Phase 3 DFI trial expected to conclude within 12 months, targeting regulatory approval and commercial launch in H1 2026.
Preparations underway for Phase 3 DFI trial in Australia to US FDA standards.
Phase II IV trial for UTI/urosepsis planned for FY26.
Ongoing expansion of manufacturing capacity and global commercial partnerships.
R327G: US FDA submission timeline
What was the outcome of the 'two strikes' vote?
What is R327's unique mechanism of action?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Recce Pharmaceuticals earnings date
AGM 20254 Nov, 2025
Next Recce Pharmaceuticals earnings date
AGM 20254 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research17 Oct 2025
Beneath the Surface: A Conversation with Epiroc CEO Helena Hedblom
Legacy, innovation, and leading one of Sweden's most influential industrial companies into a new era.
)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Frequently asked questions
Recce Pharmaceuticals Ltd is an Australian biotechnology company specializing in the development of synthetic anti-infectives to treat serious and hard-to-treat infections. The company’s proprietary technology focuses on creating broad-spectrum antibiotics designed to address antibiotic-resistant bacteria and viral infections. Recce’s primary products target bacterial sepsis, bloodstream infections, and other drug-resistant infections. Its approach to antimicrobial development aims to tackle the global challenge of antibiotic resistance through innovative, synthetic compounds that enhance treatment efficacy. The company is headquartered in Sydney, Australia, and its shares are listed on the ASX.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage